Blood filter could be key to saving High-Risk transplant patients
NCT ID NCT07200583
Summary
This study looked back at 50 patients with blood cancers or disorders who received a stem cell transplant from a partially matched family donor. Before the transplant, some patients received a special blood-filtering treatment to remove antibodies that could cause the body to reject the new cells. Researchers reviewed medical records to see if this pre-treatment helped the transplant succeed and reduced complications.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEMATOLOGIC MALIGNANCIES are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
The First Affiliated Hospital of Fujian Medical University, Fuzhou, Fujian 350001
Fuzhou, Fujian, China
Conditions
Explore the condition pages connected to this study.